Streetbeat News

Regulatory

UBS

Swiss regulator FINMA has issued strategies to oversee banks' operations, focusing on protecting depositors, insured personnel, and clients, and ensuring the proper functioning of financial markets.

Portfolio Pulse from

November 14, 2024 | 4:30 pm

TRI

Thomson Reuters has reached a $27.5 million settlement in a data privacy class action lawsuit related to its CLEAR platform. Californians have until December 6, 2024, to file claims for payments ranging from $19 to $48.

Portfolio Pulse from

November 14, 2024 | 4:30 pm

F

The National Highway Traffic Safety Administration (NHTSA) has fined Ford for delaying the recall of over 600,000 vehicles with defective parts. This is the second-largest penalty in NHTSA's history.

Portfolio Pulse from

November 14, 2024 | 4:15 pm

QTRX

Levi & Korsinsky has initiated an investigation into Quanterix Corporation (NASDAQ:QTRX) for potential securities law violations. The company disclosed an error in the capitalization of labor and overhead costs affecting inventory valuation since 2021.

Portfolio Pulse from

November 14, 2024 | 4:15 pm

BBIO

BridgeBio Pharma, Inc. is awaiting an FDA decision on its drug acoramidis for transthyretin amyloidosis, with strong clinical data suggesting likely approval. The decision is expected on November 29th. Despite past setbacks, recent data shows significant improvements, and the company has secured funding and partnerships. However, commercial success is uncertain due to competition from Pfizer and Alnylam.

Portfolio Pulse from

November 14, 2024 | 4:00 pm

NGNE

Levi & Korsinsky has initiated an investigation into Neurogene Inc. (NASDAQ:NGNE) for potential violations of federal securities laws. This follows a press release by Neurogene reporting interim clinical data from a Phase 1/2 trial of NGN-401 gene therapy for Rett syndrome.

Portfolio Pulse from

November 14, 2024 | 3:45 pm

GOOG

The U.S. Consumer Financial Protection Bureau (CFPB) is reportedly taking steps to place Alphabet's Google under formal federal supervision, according to the Washington Post. This move could present another regulatory challenge for Google.

Portfolio Pulse from

November 14, 2024 | 3:45 pm

MYGN

Levi & Korsinsky has initiated an investigation into Myriad Genetics, Inc. for potential violations of federal securities laws. This follows UnitedHealth Group's decision to stop covering Myriad's GeneSight test starting January 1, 2025.

Portfolio Pulse from

November 14, 2024 | 3:45 pm

META

The European Union has fined Meta 798 million euros for breaching antitrust rules by automatically giving Facebook users access to its Marketplace service.

Portfolio Pulse from

November 14, 2024 | 3:30 pm

CGEM

Cullinan Therapeutics is set to present preclinical data for its CD19-directed T Cell Engager, CLN-978, at the ACR Convergence 2024. The data supports the clinical development of CLN-978 in autoimmune diseases.

Portfolio Pulse from

November 14, 2024 | 3:15 pm